Presented by: Dave DeLuca, Lakshmi Chitrapu, and Ken ShitamotoThis webinar covers the following topics:Recognizing the interconnectedness of GxP and non-GxP regulations is key to developing a comprehensive compliance strategy. Integration allows organizations to streamline processes, reduce redundancies, and ensure consistency across regulatory requirements. Achieving synergy between GxP and non-GxP regulations enhances operational efficiency, mitigates risks, […]
Presented by: Dr. José C. Menezes, CSO, ValGenesisJoin us for a webinar where we’ll delve into the practical application of ICH Q12 principles for biopharma operations. Biotech processes prior to QbD use control strategies that lack understanding of criticality and definition of CPPs or CQAs. Discover how to define these parameters from manufacturing history, and […]
Created by: Kimberly Wallbank & Nicole DamourProduct complaints and reports of adverse events are unwelcome events at any company, especially if a product recall must be considered. However, these must be handled promptly and with all due diligence to prevent authentic drug- related events from negatively impacting the health and well-being of patients. This article […]
Created by: Chris Gray, Principal Consultant, CAIYour company has received an FDA warning letter, now what? As an organization finds itself in uncharted waters due to inspection results, the leader’s job is to chart a course and speed to re-inspection success without everyone jumping ship. Leaders must remember historical averages for change success hovers between […]
Created by: Harry Benson, Director, Human Performance, CAIThis paper intends to provide guidance on talent planning, with specific emphasis on role clarity. Given the flurry of activity being conducted during capital projects and transitions to operations, developing a talent plan may appear to be somewhat administrative or insufficiently urgent. This often leads site leaders to […]
31 E Kings Highway
2nd Floor Haddonfield, NJ 08033